32816
| Lns pub | 32816 |
| DatePublication | 11/14/13 |
| Recueil RG | Yes |
| Recueil FP | No |
| Documents | |
| References | |
| NonPublie | No |
| NomAffaire | Case C‑210/13 |
| LienAffaire | http://curia.europa.eu/juris/liste.jsf?num=C-210/13&language=EN |
| NomUsuel | Glaxosmithkline Biologicals and Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma v Comptroller-General of Patents, Designs and Trade Marks |
| Indicateurs | Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Concepts of ‘active ingredient’ and ‘combination of active ingredients’ — Adjuvant |
| OQP | Request for a preliminary ruling from the High Court of Justice (England and Wales), Chancery Division |
| LangueProcedure | Language of the case: English |
| numero | 201311C0312 |
